Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 4

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms × Fitness Trackers × Tumor-Agnostic × Clear all
NCT03971266 2025-09-02

Movement and Fitness Trackers in Determining Performance Status

University of Southern California

Phase NA Terminated
31 enrolled
Tumor-Agnostic

Neoplasms

NCT03757182 2024-08-27

DigiSTEPS

Cedars-Sinai Medical Center

Active not recruiting
80 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02779725 2023-11-08

SCH

University of Utah

Phase NA Completed
884 enrolled
Tumor-Agnostic

Neoplasms

NCT02659358 2017-09-25

Evaluating the Use of Wearable Biosensors and PROs to Assess Performance Status in Patients With Cancer

Cedars-Sinai Medical Center

Completed
37 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡